Texas Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$512K Sell
8,435
-640
-7% -$37.3K 0.19% 112
2025
Q4
$490K Hold
9,075
0.18% 117
2025
Q3
$409K Sell
9,075
-305
-3% -$14.2K 0.15% 123
2025
Q2
$434K Sell
9,380
-122
-1% -$5.99K 0.17% 123
2025
Q1
$580K Sell
9,502
-3,713
-28% -$216K 0.25% 99
2024
Q4
$747K Buy
+13,215
New +$738K 0.31% 90

Other funds holding BMY

Texas Bank & Trust's BMY Position: Q1 2026 in Review

Texas Bank & Trust reduced its Bristol-Myers Squibb (BMY) stake by 7.1% in Q1 2026, selling an estimated $37.3K and leaving 8,435 shares worth $512K. The position accounts for 0.19% of the portfolio, ranked #112.

Texas Bank & Trust first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $747K in Q4 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Texas Bank & Trust held 8,435 shares of Bristol-Myers Squibb worth $512K as of Q1 2026.
  • Texas Bank & Trust sold 640 Bristol-Myers Squibb shares in Q1 2026, an estimated $37.3K.
  • Bristol-Myers Squibb made up 0.19% of Texas Bank & Trust's portfolio in Q1 2026, its #112 holding.
  • Texas Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Texas Bank & Trust's Bristol-Myers Squibb position peaked at $747K in Q4 2024.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Texas Bank & Trust's 13F filing for Q1 2026, filed 30 Apr 2026.